Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector
about
The role of chromatin in adenoviral vector functionInduction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factorMechanism of protection against alcoholism by an alcohol dehydrogenase polymorphism: development of an animal model.Adenoviral vector immunity: its implications and circumvention strategies.Efficient, long-term hepatic gene transfer using clinically relevant HDAd doses by balloon occlusion catheter delivery in nonhuman primatesHepatic gene transfer as a means of tolerance induction to transgene productsMyD88-dependent silencing of transgene expression during the innate and adaptive immune response to helper-dependent adenovirus.Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.Vasoactive intestinal peptide increases hepatic transduction and reduces innate immune response following administration of helper-dependent Ad.Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular diseaseHyperactive sleeping beauty transposase enables persistent phenotypic correction in mice and a canine model for hemophilia B.Correction of hyperbilirubinemia in gunn rats using clinically relevant low doses of helper-dependent adenoviral vectorsHelper-dependent adenoviral vectors for liver-directed gene therapy.Quantification of high-capacity helper-dependent adenoviral vector genomes in vitro and in vivo, using quantitative TaqMan real-time polymerase chain reaction.NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo.Strong foreign promoters contribute to innate inflammatory responses induced by adenovirus transducing vectors.Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector.Reduction of ethanol consumption in alcohol-preferring rats by dual expression gene transferCurrent advances and future challenges in Adenoviral vector biology and targetingSafety profile of gutless adenovirus vectors delivered into the normal brain parenchyma: implications for a glioma phase 1 clinical trialSuppression of neuropil aggregates and neurological symptoms by an intracellular antibody implicates the cytoplasmic toxicity of mutant huntingtinDifferential type I interferon-dependent transgene silencing of helper-dependent adenoviral vs. adeno-associated viral vectors in vivo.Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and comparative United Network for Organ Sharing experienceGene therapy for inborn errors of liver metabolism: progress towards clinical applicationsProgress and prospects: gene therapy for genetic diseases with helper-dependent adenoviral vectors.Transgene expression up to 7 years in nonhuman primates following hepatic transduction with helper-dependent adenoviral vectors.Lasting reduction of cocaine action in neostriatum--a hydrolase gene therapy approachGene therapy for liver enzyme deficiencies: what have we learned from models for Crigler-Najjar and tyrosinemia?New insights on adenovirus as vaccine vectors.Helper-Dependent Adenoviral Vectors.Viral-based gene delivery and regulated gene expression for targeted cancer therapy.Non-viral episomal modification of cells using S/MAR elements.Countering hepatitis B virus infection using RNAi: how far are we from the clinic?Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives.Gene and cell therapy based treatment strategies for inflammatory bowel diseases.Adenoviral vector-based strategies against infectious disease and cancer.Foamy virus-adenovirus hybrid vectors for gene therapy of the arthritides.Developmental, Genetic, Dietary, and Xenobiotic Influences on Neonatal Hyperbilirubinemia.A rapid protocol for construction and production of high-capacity adenoviral vectors.Robust hepatic gene silencing for functional studies using helper-dependent adenoviral vectors.
P2860
Q27004695-259C69AE-231E-4AC6-8A03-3C2F7A52B29BQ33387265-1593C2BC-405C-4707-8882-E4074D94BD87Q33552833-357EC607-A5FF-4E10-B0F0-2276312F5A56Q33565630-8B990347-194D-43BB-864E-84130114F4C8Q33713289-07510C25-6A3F-45C6-8FF6-AC8B800200AEQ33775537-87834B79-94D7-43B8-A6C1-17537CA83459Q33832157-A9270708-68FA-4D92-919F-19D61C38C5F7Q33881920-905C3579-10DF-4ADC-B62A-E18E4D991EB9Q34025143-5AFDB2AA-6305-48B7-890F-0E2EB832A38BQ34218552-4180EAB0-5CB0-4A09-AF79-EA4FDE041F32Q34343757-4604F3BB-E7FA-4081-B493-E7178423FF22Q34774816-C94B1F09-9551-42D9-84DF-B0A46E1BC59EQ34982825-D6E185FB-4A86-4FBF-81E6-1FB1357851D7Q35069550-CA2B2F2D-5B66-48C9-A857-E32C959BE4E3Q35226121-0579FFB8-6FDE-43FF-9611-9F1197A9877AQ35568410-8C5666E7-5A38-4D41-B63C-51E1BBB01B9AQ35607028-78499D79-626D-4398-950E-DFF032FE3E73Q35772588-4CB14ED4-154D-4FE7-A099-13D557011514Q36463004-0CE187F5-8418-4D8C-A8B0-5CA410563589Q36534329-D7DFB228-5DCE-4F4C-B0CF-7718C293ED4DQ36677547-9BD68B2F-5406-498A-BEA8-6691E89766BDQ36740271-D8F145C6-7768-4EB7-BDE8-191878CE4209Q36900920-B8BED878-F71B-441D-8A2D-A9267AA7D31FQ37015311-A5905F19-41ED-43E1-B138-F386397B2B0BQ37089746-E78CD494-FBB1-4B63-89D6-A3306F21DC22Q37102059-3F9FEA99-A7C3-4483-B8C6-49424F4992C2Q37267978-05A6FD03-3721-4B35-B04B-CBBE5BEE0847Q37346064-30F77FE2-6CC9-4842-A2F4-FF8C0443542EQ37513550-5732414C-5856-49B8-BD6E-363CFB6CFDAAQ37582126-5D51BEB7-0559-4E27-BE48-0113EBF7D07DQ37641366-36DBA349-A6E6-4993-909F-B43DF8610D60Q37872790-EA736071-41BA-4FA2-9F9B-5790010EABBCQ37931159-0744F449-FA7D-4C3A-9689-70E203941CD3Q37945218-CDF6A4D7-A9FE-4294-B8A3-96314D282FDEQ37969759-1D941CF7-B8F2-43D0-8885-4B30636EC334Q38814885-83A077D9-CB09-4CE8-A672-49E2FFCB53C1Q39171777-FEF535A2-E7B5-4274-AA8F-6F1E14D7585BQ39173495-AB29FEB6-5798-4189-9D25-DF7BDDAC0374Q39859960-49093659-79FE-40FF-A98C-A4BBA5474C12Q39933737-77903063-CC9C-4AA0-BF8D-DA4D57CCA3C4
P2860
Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Lifelong elimination of hyperb ...... er-dependent adenoviral vector
@ast
Lifelong elimination of hyperb ...... er-dependent adenoviral vector
@en
Lifelong elimination of hyperb ...... er-dependent adenoviral vector
@nl
type
label
Lifelong elimination of hyperb ...... er-dependent adenoviral vector
@ast
Lifelong elimination of hyperb ...... er-dependent adenoviral vector
@en
Lifelong elimination of hyperb ...... er-dependent adenoviral vector
@nl
prefLabel
Lifelong elimination of hyperb ...... er-dependent adenoviral vector
@ast
Lifelong elimination of hyperb ...... er-dependent adenoviral vector
@en
Lifelong elimination of hyperb ...... er-dependent adenoviral vector
@nl
P2093
P2860
P3181
P356
P1476
Lifelong elimination of hyperb ...... er-dependent adenoviral vector
@en
P2093
Antony F McDonagh
Arthur L Beaudet
Brendan Lee
Milton J Finegold
Viraj P Mane
Wilma S Norona
P2860
P304
P3181
P356
10.1073/PNAS.0500930102
P407
P577
2005-03-07T00:00:00Z